Extrapyramidal Symptoms Associated with Selective Serotonin Reuptake Inhibitors: Epidemiology, Mechanisms and Management

Author： Jiménez-Jiménez F.J.

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.14, Iss.5, 2000-11, pp. : 367-379

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective serotonin reuptake inhibitors fluoxetine and fluvoxamine induce hyperglycemia by different mechanisms

By Yamada J. Sugimoto Y. Inoue K.

European Journal of Pharmacology, Vol. 382, Iss. 3, 1999-10 ,pp. : 211-215

Elsevier

Access to resources Recommend Favorite

Selective Serotonin Reuptake Inhibitors in Pregnancy

Current Medicinal Chemistry, Vol. 19, Iss. 27, 2012-09 ,pp. : 4554-4561

Bentham Science Publishers

Access to resources Recommend Favorite

Use of Selective Serotonin Reuptake Inhibitors in Children and Adolescents

By Ian C.K. Wong

Drug Safety, Vol. 27, Iss. 13, 2004-01 ,pp. : 991-1000

Adis International

Access to resources Recommend Favorite

Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy

By Alwan Sura Friedman Jan M.

CNS Drugs, Vol. 23, Iss. 6, 2009-05 ,pp. : 493-509

Adis International

Access to resources Recommend Favorite

Selective serotonin re-uptake inhibitors and the risk of bleeding

By Weinrieb Robert M Auriacombe Marc Lynch Kevin G Lewis James D

Expert Opinion on Drug Safety, Vol. 4, Iss. 2, 2005-03 ,pp. : 337-344

Informa Healthcare

Access to resources Recommend Favorite